Simpler Grants.gov #PAR-23-284

NIH NCI SPORE Grant Solicitation for Translational Cancer Research (P50 Clinical Trial Required)

The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is inviting applications for P50 SPORE (Specialized Programs of Research Excellence) grants to advance translational research in human cancers. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - Products/Services Requested: - Investigator-initiated translational research projects focused on organ-specific or biologically related groups of human cancers - Research must include clinical trials and aim for a translational human endpoint within the project period - OEMs and Vendors: - No specific OEMs or vendors are named, as this is a research grant opportunity rather than a procurement of products - Unique/Notable Requirements: - Research must be translational and based on human biology - Projects must address prevention, early detection, diagnosis, or treatment of cancer - Eligible applicants include government agencies, nonprofits, educational institutions, and businesses (excluding foreign organizations) - Clinical trial component is required - Place of Performance: - National Institutes of Health (federal office)

Description

The National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE). The program funds translational research aimed at improving prevention, early detection, diagnosis, and treatment of organ-specific cancers or related groups of cancers. Research must be translational, focusing on human biology and aiming to reach a translational human endpoint within the project period. Eligible applicants include various government entities, nonprofits, educational institutions, and businesses, excluding foreign organizations.

View original listing